Jan 22, 2020 / 10:30AM GMT
Operator
[Ladies and gentlemen, good day, and welcome to the Q3 FY '20 earnings conference call of Alembic Pharmaceuticals Limited.
On the call today, we have with us, Mr. Pranav Amin, Managing Director; Mr. R.K. Baheti, Director, Finance and CFO; Mr. Mitanshu Shah, Head, Finance; Mr. Jesal Shah, Head, Strategy; and Mr. Ajay Kumar Desai, Senior VP, Finance. (Operator Instructions) Please note that this conference is being recorded.
I now hand the conference over to Mr. R.K. Baheti. Thank you, and over to you, sir.]
Raj Kumar Shreeram Baheti - Alembic Pharmaceuticals Limited - Director of Finance, CFO & Executive Director
Thank you very much. Good afternoon, everyone. Thank you all for joining our third quarter results conference call. I'm sure you would have received our results by now. However, let me briefly take you through the numbers for the quarter ended 31st December, 2019 -- 2020, I'm sorry. Sorry, 2019, 31st December, 2019.
During the quarter, total revenue grew by 19% to INR 1,209 crores. EBITDA at INR 332 crores is 27% of sales
Q3 2020 Alembic Pharmaceuticals Ltd Earnings Call Transcript
Jan 22, 2020
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers